Old Web
English
Sign In
Acemap
>
authorDetail
>
Kinfemichael Gedif
Kinfemichael Gedif
Novartis
Medicine
Clinical trial
Ophthalmology
Aflibercept
Visual acuity
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data.
2021
American Journal of Ophthalmology
Chirag Jhaveri
Charles C. Wykoff
Arshad M. Khanani
Chiara M. Eandi
Andrew Chang
Guruprasad B
Kinfemichael Gedif
Michael C. Singer
Show All
Source
Cite
Save
Citations (1)
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK.
2021
British Journal of Ophthalmology
Yuichiro Ogura
Glenn J. Jaffe
Chui Ming Gemmy Cheung
Gregg T. Kokame
Tomohiro Iida
Kanji Takahashi
Won-Ki Lee
Andrew Chang
Jordi Monés
Divya DSouza
Georges Weissgerber
Kinfemichael Gedif
Adrian Koh
Show All
Source
Cite
Save
Citations (0)
HAWK and HARRIER 48-week data: potential for treatment interval extension in patients with nAMD disease activity at Week 16
2021
Investigative Ophthalmology & Visual Science
Ramin Tadayoni
Glenn J. Jaffe
Frank G. Holz
Ursula Schmidt-Erfurth
Kanji Takahashi
Gemmy Cheung
Seenu Hariprasad
Kinfemichael Gedif
Rasmus Olsen
Catherine Best
Peter K. Kaiser
Show All
Source
Cite
Save
Citations (0)
1